TME-SW
01698
XIAOMI-W
01810
BEKE-W
02423
4
NTES-S
09999
5
BIDU-SW
09888
(Q9)Sep 30, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2018 | (FY)Dec 31, 2017 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | 84.07%-54.4M | -28.09%-469.01M | ---341.49M | 41.61%-44.63M | -33.44%-366.14M | ---76.44M | 39.82%-274.39M | ---455.98M | -452.36%-1.29B | 85.07%-122.7M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | 63.69%-7.42M | -134.33%-26.38M | ---20.43M | -381.48%-6.24M | -42.25%-11.26M | ---1.3M | -15.32%-7.91M | ---6.86M | -230.57%-36.95M | -69.97%-41.06M |
Dividend (income)- adjustment | ---- | ---- | ---- | ---- | ---- | ---- | 61.59%-285K | ---742K | ---- | ---- |
Attributable subsidiary (profit) loss | -24.80%1.57M | 123.20%2.54M | --2.09M | 276.72%1.59M | -76.16%1.14M | --421K | -38.10%4.77M | --7.71M | 4.93%1.57M | 7.31%3.07M |
Impairment and provisions: | 736.08%57.59M | -61.42%32.67M | --6.89M | -118.68%-2.51M | 112.38%84.67M | --13.46M | -39.88%39.87M | --66.32M | -158.55%-2.1M | 210.80%5.55M |
-Impairmen of inventory (reversal) | ---- | -98.78%370K | ---- | ---- | --30.38M | ---- | ---- | ---3.41M | ---- | ---- |
-Other impairments and provisions | 736.08%57.59M | -40.51%32.3M | --6.89M | -118.68%-2.51M | 36.19%54.3M | --13.46M | -42.82%39.87M | --69.72M | -158.55%-2.1M | 210.80%5.55M |
Revaluation surplus: | 1,819.64%7.43M | -88.18%3.05M | --387K | 237.14%16.06M | -80.16%25.78M | ---11.71M | 10.33%129.95M | --117.79M | 4,034.27%1.18B | -87.38%91.29M |
-Derivative financial instruments fair value (increase) | -1,016.13%-284K | -105.83%-415K | --31K | -258.79%-1.46M | 316.50%7.12M | --922K | -84.66%1.71M | --11.14M | 90.93%-8.68M | -495.47%-133.69M |
-Other fair value changes | 2,066.57%7.71M | -81.44%3.46M | --356K | 238.72%17.53M | -85.45%18.66M | ---12.63M | 20.25%128.24M | --106.65M | 855.43%1.19B | -69.84%224.98M |
Asset sale loss (gain): | 98.32%-4K | 86.95%-171K | ---238K | -670.27%-211K | 65.05%-1.31M | --37K | -159.02%-3.75M | ---1.45M | 82.74%-29K | -476.57%-15.29M |
-Available for sale investment sale loss (gain) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -334.09%-18.22M |
-Loss (gain) from sale of subsidiary company | ---- | 149.08%425K | ---- | ---- | 73.01%-866K | ---- | -400.62%-3.21M | ---641K | ---- | 24.91%1.83M |
-Loss (gain) on sale of property, machinery and equipment | 98.32%-4K | -34.23%-596K | ---238K | -670.27%-211K | 17.63%-444K | --37K | 33.13%-539K | ---806K | -108.79%-29K | 1,194.19%1.11M |
Depreciation and amortization: | -1.64%15.55M | -4.34%21.03M | --15.81M | -7.88%5.2M | 9.00%21.99M | --5.65M | -2.18%20.17M | --20.62M | 34.59%9.86M | 20.32%14.82M |
-Depreciation | -1.08%7.81M | -10.08%10.45M | --7.9M | -12.92%2.64M | 39.53%11.63M | --3.04M | 54.58%8.33M | --5.39M | 19.96%8.02M | 17.27%13.5M |
-Amortization of intangible assets | -27.83%3.23M | -0.18%5.96M | --4.47M | -0.20%1.49M | 22.22%5.97M | --1.49M | 71.17%4.89M | --2.86M | 187.34%1.84M | 63.90%1.32M |
Financial expense | -18.85%34.3M | -23.15%64.87M | --42.27M | -45.44%12.55M | 6.09%84.41M | --23M | -28.59%79.57M | --111.42M | -2.57%79.42M | 128.47%150.85M |
Exchange Loss (gain) | 391.10%8.44M | -80.59%2.65M | --1.72M | -85.10%1.1M | 517.31%13.66M | --7.37M | 456.03%2.21M | --398K | -25.12%1.54M | 61.07%-3.82M |
Special items | -100.04%-99K | 51,866.02%344.24M | --257.24M | -208.81%-284K | 99.06%-665K | --261K | -4,742.54%-70.8M | ---1.46M | --216K | -148.60%-3.96M |
Operating profit before the change of operating capital | 276.14%62.97M | 83.42%-24.5M | ---35.75M | 55.70%-17.39M | -83.32%-147.73M | ---39.25M | 43.34%-80.59M | ---142.24M | 54.50%-54.45M | 280.07%78.77M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | -112.92%-16.8M | 444.68%131.75M | --130.08M | 303.59%130.63M | 144.65%24.19M | ---64.17M | -128.79%-54.17M | --188.14M | 66.65%-50.79M | 88.20%-63.14M |
Accounts receivable (increase)decrease | 122.89%779.25M | -445.29%-3.34B | ---3.4B | -0.05%-3.46B | 50.55%-612.83M | ---3.46B | 31.86%-1.24B | ---1.82B | -38.10%-1.1B | 71.22%-433.43M |
Accounts payable increase (decrease) | -101.90%-74.65M | 52.71%3.59B | --3.94B | 3.67%3.53B | 39.66%2.35B | --3.4B | -12.82%1.68B | --1.93B | -127.91%-444.5M | 126.16%1.79B |
Special items for working capital changes | -24.10%-365.9M | 88.51%-140.26M | ---294.83M | -530.00%-262.84M | -54.14%-1.22B | ---41.72M | -63.85%-791.84M | ---483.27M | ---- | ---- |
Cash from business operations | 14.98%384.87M | -45.93%211.8M | --334.73M | 58.84%-83.26M | 180.91%391.73M | ---202.29M | -48.09%-484.14M | ---326.92M | -416.66%-1.65B | 206.65%1.38B |
Other taxs | 77.91%-19K | 86.14%-88K | ---86K | 93.00%-41K | -1,251.06%-635K | ---586K | 96.21%-47K | ---1.24M | 74.40%-1.45M | ---6.05M |
Net cash from operations | 15.00%384.85M | -45.87%211.71M | --334.65M | 58.94%-83.3M | 180.77%391.09M | ---202.87M | -47.55%-484.19M | ---328.16M | -420.42%-1.65B | 206.18%1.37B |
Cash flow from investment activities | ||||||||||
Interest received - investment | -36.47%9.76M | 798.82%28.29M | --15.36M | 248.50%1.62M | -57.88%3.15M | --466K | 8.21%7.47M | --6.91M | -50.41%2.93M | 26.17%8.67M |
Dividend received - investment | ---- | ---- | ---- | ---- | ---- | ---- | -61.59%285K | --742K | ---- | ---- |
Loan receivable (increase) decrease | 145.94%1.57M | -901.20%-14M | ---3.41M | ---3.44M | -86.10%1.75M | --0 | --12.57M | ---- | 88,154.84%27.36M | -297.87%-29.05M |
Decrease in deposits (increase) | -0.56%-366.27M | 50.11%-524.92M | ---364.22M | 120.62%13.91M | -1,970.49%-1.05B | ---67.46M | -318.89%-50.82M | ---12.13M | 337.51%250.52M | -7.86%-47.12M |
Sale of fixed assets | -57.09%127K | 6.27%661K | --296K | -16.97%225K | -59.05%622K | --271K | -23.40%1.52M | --1.98M | -91.01%347K | 37.38%5.5M |
Purchase of fixed assets | -1,507.07%-9.32M | 59.84%-11.24M | ---580K | 94.09%-441K | 58.26%-27.98M | ---7.46M | -221.92%-67.03M | ---20.82M | -2.64%-8.87M | 30.58%-14.9M |
Purchase of intangible assets | ---118K | 59.70%-27K | ---- | ---- | -204.55%-67K | ---- | 98.48%-22K | ---1.45M | -251.06%-1.49M | 57.35%-2.38M |
Sale of subsidiaries | ---- | ---- | ---- | ---- | -93.29%1.03M | ---- | 620.63%15.37M | --2.13M | ---- | -89.54%182K |
Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 59.01%-5.1M |
Recovery of cash from investments | 97.93%466.23M | 46.95%283.68M | --235.56M | -98.67%275K | 30.34%193.05M | --20.62M | -61.95%148.12M | --389.31M | -90.63%11.43M | -84.45%196.92M |
Cash on investment | -78.96%-465.95M | -87.25%-308.96M | ---260.37M | -120.81%-24.5M | -12.79%-165M | ---11.1M | 54.58%-146.29M | ---322.09M | -118.28%-141.85M | 89.96%-102.65M |
Other items in the investment business | ---- | ---- | ---- | ---- | ---- | ---- | --10.37M | ---- | 548.52%2.37B | 77.86%2.26B |
Net cash from investment operations | 3.55%-363.98M | 47.74%-546.51M | ---377.36M | 80.89%-12.35M | -1,427.36%-1.05B | ---64.65M | -253.58%-68.46M | --44.58M | 696.67%2.51B | 55.62%2.27B |
Net cash before financing | 148.87%20.87M | 48.85%-334.8M | ---42.71M | 64.24%-95.66M | -18.44%-654.57M | ---267.52M | -94.88%-552.65M | ---283.59M | 3.31%859.26M | 2,087.75%3.64B |
Cash flow from financing activities | ||||||||||
New borrowing | -58.24%207.29M | -49.09%750.57M | --496.44M | -46.58%253.73M | -15.64%1.47B | --474.96M | 16.35%1.75B | --1.5B | -42.29%2.83B | 124.21%12.68B |
Refund | 54.22%-375.45M | 39.98%-1.01B | ---820.17M | 17.97%-351.91M | -7.13%-1.69B | ---428.99M | 9.69%-1.58B | ---1.75B | 31.07%-4.02B | -169.49%-16.38B |
Issuing shares | ---- | --907K | --13K | ---- | ---- | ---- | --20.06M | ---- | -99.98%79K | 13,188.01%430M |
Interest paid - financing | 21.12%-34.03M | 22.92%-65.34M | ---43.14M | 50.23%-11.87M | -3.70%-84.77M | ---23.84M | 30.18%-81.74M | ---117.08M | -11.93%-87.39M | -149.74%-148.49M |
Absorb investment income | ---- | ---- | ---- | ---- | ---- | ---- | 109.48%58.31M | ---615.11M | ---- | ---- |
Issuance expenses and redemption of securities expenses | 61.98%-281K | ---1.76M | ---739K | ---- | ---- | ---- | -135.68%-308.86M | --865.66M | ---100M | ---- |
Other items of the financing business | -38.57%313.12M | -47.16%543.43M | --509.72M | 60.31%221.7M | 43.44%1.03B | --138.3M | 96.33%716.96M | --365.18M | ---28.83M | 56.78%-5.66M |
Net cash from financing operations | -24.71%104.4M | -71.16%209.41M | --138.66M | -30.69%110.63M | 27.62%726.09M | --159.63M | 135.78%568.95M | --241.31M | -143.72%-1.41B | -1,596.30%-3.43B |
Effect of rate | -184.16%-425K | 196.55%86K | --505K | 15.17%-246K | 112.66%29K | ---290K | 20.21%-229K | ---287K | -198.97%-2.3M | -156.24%-7.03M |
Net Cash | 30.56%125.27M | -275.33%-125.4M | --95.95M | 113.88%14.98M | 338.71%71.52M | ---107.89M | 138.56%16.3M | ---42.28M | -314.26%-546.4M | 696.74%212.76M |
Begining period cash | -28.73%310.9M | 19.62%436.21M | --436.21M | 19.62%436.21M | 4.61%364.67M | --364.67M | -10.88%348.59M | --391.16M | 33.80%814.34M | -3.67%608.61M |
Cash at the end | -18.19%435.75M | -28.73%310.9M | --532.67M | 75.82%450.95M | 19.62%436.21M | --256.49M | 4.61%364.67M | --348.59M | -69.32%265.64M | 33.80%814.34M |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.